Dr. James T D'Olimpio, MD
Claim this profileClinical Research Alliance
Affiliated Hospitals
Clinical Research Alliance
Clinical Research Alliance, Inc.
Clinical Trials James T D'Olimpio, MD is currently running
Pirtobrutinib
for Immune Thrombocytopenic Purpura
The purpose of the phase 1 part of this study is to evaluate how well pirtobrutinib is tolerated and what side effects may occur. The phase 2 part of the study will further investigate efficacy and safety of multiple pirtobrutinib dosages versus placebo. The study drug will be administered orally in participants with Primary Immune Thrombocytopenia (ITP). Blood tests will be performed to check how much pirtobrutinib gets into the bloodstream and how long it takes the body to eliminate it. The study will last up to approximately 16 weeks for phase 1 dose-escalation and 28 weeks for phase 2 dose-optimization, excluding screening.
Recruiting
0 awards
Phase 1 & 2
4 criteria
Fianlimab + Cemiplimab
for Non-Small Cell Lung Cancer
This trial is testing a new drug combination for patients with advanced lung cancer. It aims to see if using two drugs together is more effective than one alone. The study also looks at side effects, how the drugs are processed in the body, and their impact on quality of life.
Recruiting
0 awards
Phase 2 & 3
More about James T D'Olimpio, MD
Clinical Trial Related
1 year of experience running clinical trials · Led 16 trials as a Principal Investigator · 9 Active Clinical Trials
Treatments James T D'Olimpio, MD has experience with
- Pirtobrutinib
- Rituximab
- Abemaciclib
- Cisplatin
- Pemetrexed
- Cemiplimab
Breakdown of trials James T D'Olimpio, MD has run
Chronic Lymphocytic Leukemia
Lymphoma
Mixed-Cell Lymphoma
Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does James T D'Olimpio, MD specialize in?
James T D'Olimpio, MD focuses on Chronic Lymphocytic Leukemia and Lymphoma. In particular, much of their work with Chronic Lymphocytic Leukemia has involved treating patients, or patients who are undergoing treatment.
Is James T D'Olimpio, MD currently recruiting for clinical trials?
Yes, James T D'Olimpio, MD is currently recruiting for 9 clinical trials in Westbury New York. If you're interested in participating, you should apply.
Are there any treatments that James T D'Olimpio, MD has studied deeply?
Yes, James T D'Olimpio, MD has studied treatments such as Pirtobrutinib, Rituximab, Abemaciclib.
What is the best way to schedule an appointment with James T D'Olimpio, MD?
Apply for one of the trials that James T D'Olimpio, MD is conducting.
What is the office address of James T D'Olimpio, MD?
The office of James T D'Olimpio, MD is located at: Clinical Research Alliance, Westbury, New York 11590 United States. This is the address for their practice at the Clinical Research Alliance.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.